Jabbour E - Search Results

1

Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome.

Dimicoli S, Jabbour E, Borthakur G, Kadia T, Estrov Z, Yang H, Kelly M, Pierce S, Kantarjian H, Garcia-Manero G. Dimicoli S, et al. Among authors: jabbour e. Am J Hematol. 2012 Jan;87(1):127-9. doi: 10.1002/ajh.22198. Epub 2011 Nov 10. Am J Hematol. 2012. PMID: 22072492 Free PMC article. Clinical Trial.

2

Clinical activity of farnesyl transferase inhibitors in hematologic malignancies: possible mechanisms of action.

Jabbour E, Kantarjian H, Cortes J. Jabbour E, et al. Leuk Lymphoma. 2004 Nov;45(11):2187-95. doi: 10.1080/10428190412331272677. Leuk Lymphoma. 2004. PMID: 15512806 Review.

3

Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986.

Saba R, Jabbour E, Giles F, Cortes J, Talpaz M, O'Brien S, Freireich EJ, Garcia-Manero G, Kantarjian H, Verstovsek S. Saba R, et al. Among authors: jabbour e. Cancer. 2005 Jun 15;103(12):2551-7. doi: 10.1002/cncr.21086. Cancer. 2005. PMID: 15861412 Free article. Clinical Trial.

4

New agents in myelodysplastic syndromes.

Jabbour EJ, Giles FJ. Jabbour EJ, et al. Curr Hematol Rep. 2005 May;4(3):191-9. Curr Hematol Rep. 2005. PMID: 15865871 Review.

5

2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.

Jabbour E, Verstovsek S, Giles F, Gandhi V, Cortes J, O'Brien S, Plunkett W, Garcia-Manero G, Jackson CE, Kantarjian H, Andreeff M. Jabbour E, et al. Cancer. 2005 Aug 1;104(3):541-6. doi: 10.1002/cncr.21186. Cancer. 2005. PMID: 15977212 Free article.

6

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.

Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, Pierce S, Thomas D, Ravandi F, Wierda WG, Giles F, Ferrajoli A, Jabbour E, Keating MJ, Bueso-Ramos CE, Estey E, Garcia-Manero G. Oki Y, et al. Among authors: jabbour e. Blood. 2006 Feb 1;107(3):880-4. doi: 10.1182/blood-2005-06-2450. Epub 2005 Aug 25. Blood. 2006. PMID: 16123215 Free article.

7

Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate.

Jabbour E, Kantarjian H, O'Brien S, Rios MB, Abruzzo L, Verstovsek S, Garcia-Manero G, Cortes J. Jabbour E, et al. Blood. 2006 Jan 15;107(2):480-2. doi: 10.1182/blood-2005-05-1816. Epub 2005 Sep 29. Blood. 2006. PMID: 16195326 Free article.

8

Clinical experience with decitabine in North American patients with myelodysplastic syndrome.

Yee KW, Jabbour E, Kantarjian HM, Giles FJ. Yee KW, et al. Among authors: jabbour e. Ann Hematol. 2005 Dec;84 Suppl 1:18-24. doi: 10.1007/s00277-005-0019-7. Ann Hematol. 2005. PMID: 16273408

9

Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.

Giles F, Verstovsek S, Thomas D, Gerson S, Cortes J, Faderl S, Ferrajoli A, Ravandi F, Kornblau S, Garcia-Manero G, Jabbour E, O'Brien S, Karsten V, Cahill A, Yee K, Albitar M, Sznol M, Kantarjian H. Giles F, et al. Among authors: jabbour e. Clin Cancer Res. 2005 Nov 1;11(21):7817-24. doi: 10.1158/1078-0432.CCR-05-1070. Clin Cancer Res. 2005. PMID: 16278404 Clinical Trial.

10

Adult acute lymphoblastic leukemia.

Jabbour EJ, Faderl S, Kantarjian HM. Jabbour EJ, et al. Mayo Clin Proc. 2005 Nov;80(11):1517-27. doi: 10.4065/80.11.1517. Mayo Clin Proc. 2005. PMID: 16295033 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

892 results

Search Page

Filters